Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print

Microtest Labs Offers Fish Embryo Toxicity Testing



Published December 4, 2013
Related Searches: Development Testing
Microtest Laboratories is adding OECD Fish Embryo Toxicity Testing to its portfolio of services. The European Commission has recently added three pharmaceutical compounds to its pollutant watch list, citing them as potential environmental risks to surface water. The FET test is an approved OECD (Organization for Economic Co-Operative Development) guideline, published in August, 2013.
 
“Fish Embryo Toxicity (FET) testing has been developed for environmental and hazard classification applications. The test utilizes the embryo of the Zebrafish and exposes it to various compounds to observe potential toxic effects, thus making FET an ideal method to use in monitoring or investigating environmental cases,” said Steven Richter, Ph.D., president and scientific director of Microtest Laboratories — and former FDA official.
 
“Microtest Laboratories is deeply experienced in fish embryo toxicity testing. We are particularly well-suited to undertake FET testing due to the expertise we’ve developed in creating our Zebrafish Embryo Toxicity (ZET) test, which we’ve been providing as a preliminary screening method in the biocompatibility testing of medical devices and polymers.”
 


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On